Evidence map›Paper›PMID 32781430›Full record

ArticleMolecular therapy. Nucleic acids2020

Inhibition of p66Shc Oxidative Signaling via CA-Induced Upregulation of miR-203a-3p Alleviates Liver Fibrosis Progression.

Zhecheng Wang, Yan Zhao, Huanyu Zhao, Junjun Zhou, Dongcheng Feng, Fan Tang, Yang Li, Li Lv, Zhao Chen, Xiaodong Ma and 2 more

Open access · goldAbstract read
In one paragraph

Article in Molecular therapy. Nucleic acids, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. The p66International journal of molecular sciences · 2023
    Review
  5. Mitochondrial heterogeneity in diseases.Signal transduction and targeted therapy · 2023
    Review
  6. Article
  7. Article
  8. Metabolic Consequences of Gestational Cannabinoid Exposure.International journal of molecular sciences · 2021
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Zhecheng WangDepartment of Pharmacology, Dalian Medical University, Dalian 116044, China.
Yan ZhaoDepartment of Pharmacology, Dalian Medical University, Dalian 116044, China.
Huanyu ZhaoDepartment of Pharmacology, Dalian Medical University, Dalian 116044, China.
Junjun ZhouDepartment of Pharmacology, Dalian Medical University, Dalian 116044, China.
Dongcheng FengDepartment of General Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian 116023, China.
Fan TangDepartment of Pharmacology, Dalian Medical University, Dalian 116044, China.
Yang LiDepartment of General Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian 116023, China.
Li LvDepartment of Pharmacology, Dalian Medical University, Dalian 116044, China.
Zhao ChenDepartment of General Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian 116023, China.
Xiaodong MaDepartment of Pharmacology, Dalian Medical University, Dalian 116044, China.
Xiaofeng TianDepartment of General Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian 116023, China. Electronic address: txfdl@dmu.edu.cn.
Jihong YaoDepartment of Pharmacology, Dalian Medical University, Dalian 116044, China. Electronic address: yaojihong65@hotmail.com.
Dalian Medical University · CNSecond Affiliated Hospital of Dalian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We previously found that inhibition of p66Shc confers protection against hepatic stellate cell (HSC) activation during liver fibrosis. However, the effect of p66Shc on HSC proliferation, as well as the mechanism by which p66Shc is modulated, remains unknown. Here, we elucidated the effect of p66Shc on HSC proliferation and evaluated microRNA (miRNA)-p66Shc-mediated reactive oxidative species (ROS) generation in liver fibrosis. An in vivo model of carbon tetrachloride (CCl

Identifiers

PMID32781430
PMCPMC7417942
OpenAlexW3041136118

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.